BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17549068)

  • 1. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
    Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
    Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
    Ozawa S
    Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new series of review articles on drug metabolizing enzymes: nomenclature of isoenzyme families, genetic organization, polymorphisms, substrate specificities, clinical relevance and role in carcinogenesis.
    Bolt HM; Hengstler JG
    Arch Toxicol; 2008 Jul; 82(7):413-4. PubMed ID: 18528684
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes.
    Welch RA; Lazaruk K; Haque KA; Hyland F; Xiao N; Wronka L; Burdett L; Chanock SJ; Ingber D; De La Vega FM; Yeager M
    Hum Mutat; 2008 May; 29(5):750-6. PubMed ID: 18327779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.
    Stingl JC; Brockmöller J; Viviani R
    Mol Psychiatry; 2013 Mar; 18(3):273-87. PubMed ID: 22565785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of genotyping and phenotyping of biotransformation in therapeutic drug monitoring].
    Barré J
    Therapie; 2001; 56(3):251-5. PubMed ID: 11475803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.
    Korashy HM; Elbekai RH; El-Kadi AO
    Xenobiotica; 2004 Jan; 34(1):1-29. PubMed ID: 14742134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
    Wijnen PA; Op den Buijsch RA; Drent M; Kuijpers PM; Neef C; Bast A; Bekers O; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 13. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?
    Gardiner SJ; Begg EJ
    Pharmacogenet Genomics; 2005 May; 15(5):365-9. PubMed ID: 15864139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5' nuclease chain reaction assay.
    Hiratsuka M; Agatsuma Y; Omori F; Narahara K; Inoue T; Kishikawa Y; Mizugaki M
    Biol Pharm Bull; 2000 Oct; 23(10):1131-5. PubMed ID: 11041238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
    Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic drug monitoring: clinical practice].
    Widmer N; Werner D; Grouzmann E; Eap CB; Marchetti O; Fayet A; Csajka C; Decosterd LA; Buclin T
    Rev Med Suisse; 2008 Jul; 4(165):1649-50, 1652-60. PubMed ID: 18767291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism.
    Krämer SD; Testa B
    Chem Biodivers; 2008 Dec; 5(12):2465-578. PubMed ID: 19089818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of drug metabolism.
    Nebert DW; Dieter MZ
    Pharmacology; 2000 Sep; 61(3):124-35. PubMed ID: 10971198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors in drug metabolism.
    Belle DJ; Singh H
    Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.